DDrare: Database of Drug Development for Rare Diseases

Duloxetine hydrochloride (DrugBank: Duloxetine)

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	1
13	Multiple sclerosis/Neuromyelitis optica	1

6. Parkinson disease [ 2,123 clinical trials, 2,046 drugs, (DrugBank: 324 drugs), 183 drug target genes, 198 drug target pathways]

Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,123 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00437125 (ClinicalTrials.gov)	March 2007	16/2/2007	Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease	An Open Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson's Disease	Major Depressive Disorder;Idiopathic Parkinson Disease	Drug: Duloxetine hydrochloride	Eli Lilly and Company	NULL	Completed	30 Years	75 Years	All	151	Phase 4	Italy

13. Multiple sclerosis/Neuromyelitis optica [ 3,050 clinical trials, 2,147 drugs, (DrugBank: 348 drugs), 244 drug target genes, 228 drug target pathways]

Searched query = "Multiple sclerosis/Neuromyelitis optica", "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 3,050 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00755807 (ClinicalTrials.gov)	October 2008	17/9/2008	Duloxetine for Multiple Sclerosis Pain	Duloxetine in Patients With Central Neuropathic Pain Due to Multiple Sclerosis.	Multiple Sclerosis	Drug: Duloxetine Hydrochloride (HCI);Drug: Placebo	Eli Lilly and Company	NULL	Completed	18 Years	N/A	All	239	Phase 3	United States;Belgium;Canada;Poland